Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Other financing activities (2023 - 2024)

60 Degrees Pharmaceuticals (SXTP) has disclosed Other financing activities for 2 consecutive years, with $96217.0 as the latest value for Q3 2024.

  • On a quarterly basis, Other financing activities rose 2382.38% to $96217.0 in Q3 2024 year-over-year; TTM through Sep 2024 was $102077.0, a N/A change, with the full-year FY2023 number at $150420.0, up 119.18% from a year prior.
  • Other financing activities was $96217.0 for Q3 2024 at 60 Degrees Pharmaceuticals, up from -$10357.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $5.4 million in Q1 2023 to a low of -$5.2 million in Q2 2023.